Englefield Capital has closed its second European mid-market fund with Euro 1.06 billion in capital commitments. www.englefieldcapital.com
Tailwind Capital held a $320 million first close on its first fund since spinning off from Thomas Weisel Partners last January, according to Private Equity Insider. The overall target is $750 million, with Atlantic-Pacific Capital serving as placement agent. www.tailwindcapital.com
New York Life Investment Management has closed its second mezzanine fund with around $260 million in capital commitments, according to a regulatory filing. www.nylim.com
Giuliani Partners is planning to sell its boutique I-banking unit Giuliani Capital Advisors, according to The New York Times. The move is being made in preparation of firm founder Rudy Giuliani's expected presidential campaign. www.giulianipartners.com
Richard Whitney has joined New Enterprise Associates as a venture partner in the firm's Menlo Park, Calif. office. He previously served as founder and managing member of Whitney Capital, a private equity firm focused on the healthcare services and products space. Before that, he was executive chairman of Specialty Labs and CFO of DaVita Inc. […]
Betty Hung has joined Vista Equity Partners as operating vice president. She previously was with Garnett & Helfirch Capital as vice president of portfolio company operations. www.vistaequitypartners.com
Jonathan Noble has joined Montgomery Law Group as a partner in the firm's corporate and securities practice. He previously founded by Noble Law Group in Palo Alto, and before that was an attorney with Gunderson Dettmer. www.montgomerylawgroup.com
Berkshire Partners has promoted Michael Ascione to the position of managing director. He joined the firm in 2001, and had been serving as a principal. www.berkshirepartners.com
Alvarez & Marsal Transaction Advisory Group has staffed up with the following hires: Geoff Weber, formerly of KPMG, as a Chicago-based director; Andrew Henoch, formerly of PricewaterhouseCoopers, as a Chicago-based senior associate; Alexander Chan, formerly of Deloitte & Touche, as a San Francisco-based director and; Brad Goldsmith, formerly of Ernst & Young, as a New […]
SARcode Corp., a San Francisco-based developer of LFA-1 inhibitors to treat inflammatory diseases, has raised $25 million in Series A funding co-led by Alta Partners and Clarus Ventures. The company had called down $5 million of the deal as of January 2, according to a regulatory filing.